Evidence for a Pan-Neurodegenerative Disease Response in Huntington's and Parkinson's Disease Expression Profiles

被引:27
|
作者
Labadorf, Adam [1 ,2 ]
Choi, Seung H. [3 ]
Myers, Richard H. [1 ,2 ,3 ]
机构
[1] Boston Univ, Bioinformat Program, Boston, MA 02215 USA
[2] Boston Univ, Dept Neurol, Boston, MA 02215 USA
[3] Boston Univ, Sch Publ Hlth, Biostat, Boston, MA USA
来源
基金
美国国家卫生研究院;
关键词
Huntington disease; Parkinson disease; mRNA-seq; neuroinflammation; bioinformatics and computational biology; neurodegenerative diseases; immune system; NF-KAPPA-B; MITOCHONDRIAL-DNA DAMAGE; ELEMENT-BINDING PROTEIN; GENE-EXPRESSION; MOUSE MODEL; PATHOLOGY; STRESS; REDD1; PHOSPHORYLATION; RTP801/REDD1;
D O I
10.3389/fnmol.2017.00430
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Huntington's and Parkinson's Diseases (HD and PD) are neurodegenerative disorders that share some pathological features but are disparate in others. For example, while both diseases are marked by aberrant protein aggregation in the brain, the specific proteins that aggregate and types of neurons affected differ. A better understanding of the molecular similarities and differences between these two diseases may lead to a more complete mechanistic picture of both the individual diseases and the neurodegenerative process in general. We sought to characterize the common transcriptional signature of HD and PD as well as genes uniquely implicated in each of these diseases using mRNA-Seq data from post mortem human brains in comparison to neuropathologically normal controls. The enriched biological pathways implicated by HD differentially expressed genes show remarkable consistency with those for PD differentially expressed genes and implicate the common biological processes of neuroinflammation, apoptosis, transcriptional dysregulation, and neuron-associated functions. Comparison of the differentially expressed (DE) genes highlights a set of consistently altered genes that span both diseases. In particular, processes involving nuclear factor kappa-light-chain-enhancer of activated B cells (NFkB) and transcription factor cAMP response element-binding protein (CREB) are the most prominent among the genes common to HD and PD. When the combined HD and PD data are compared to controls, relatively few additional biological processes emerge as significantly enriched, suggesting that most pathways are independently seen within each disorder. Despite showing comparable numbers of DE genes, DE genes unique to HD are enriched in far more coherent biological processes than the DE genes unique to PD, suggesting that PD may represent a more heterogeneous disorder. The complexity of the biological processes implicated by this analysis provides impetus for the development of better experimental models to validate the results.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Neuropsychological and behavioral aspects of transplants in Parkinson's disease and Huntington's disease
    Diederich, NJ
    Goetz, CG
    BRAIN AND COGNITION, 2000, 42 (02) : 294 - 306
  • [32] The effect of Parkinson's disease and Huntington's disease on human visuomotor learning
    Manuel Gutierrez-Garralda, Juan
    Moreno-Briseno, Pablo
    Boll, Marie-Catherine
    Morgado-Valle, Consuelo
    Campos-Romo, Aurelio
    Diaz, Rosalinda
    Fernandez-Ruiz, Juan
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2013, 38 (06) : 2933 - 2940
  • [33] Attentional dysfunction and smooth pursuit in Parkinson's disease and Huntington's disease
    Henderson, T.
    Georgiou-Karistianis, N.
    White, O.
    Williams, D.
    Churchyard, A.
    Fielding, J.
    MOVEMENT DISORDERS, 2010, 25 (07) : S319 - S319
  • [34] Spatial cognitive shifting in Huntington's disease and Parkinson's disease.
    Dimovski, EB
    Stout, JC
    Wylie, SA
    Siemers, ER
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 1999, 14 (01) : 126 - 126
  • [35] Protein aggregation in neurodegenerative disorders: Alzheimer's disease and Parkinson's disease
    Iwatsubo, T
    FRONTIERS OF THE MECHANISMS OF MEMORY AND DEMENTIA, 2000, (1200): : 137 - 138
  • [36] Parkinson's disease -: a multifactorial neurodegenerative disorder
    Riess, O
    Krüger, R
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1999, (56): : 113 - 125
  • [37] Myeloperoxidase in the neurodegenerative process of Parkinson's disease
    Teismann, P.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 (03) : 99 - 102
  • [38] Neurodegenerative disease: Pieces of the Parkinson's puzzle
    Ozawa Y.
    Nature Reviews Neuroscience, 2010, 11 (12) : 787 - 787
  • [39] Impaired hypocretin neurotransmission in Huntington's and Parkinson's disease
    Fronczek, R.
    Overeem, S.
    Hegeman, I.
    Roelandse, F.
    Van Pelt, J.
    Maat-Schieman, M.
    Van Duinen, S.
    Roos, R.
    Lammers, G.
    SLEEP, 2006, 29 : A299 - A299
  • [40] Clinical neurotransplantation protocol for Huntington's and Parkinson's disease
    Lopez, William Omar Contreras
    Nikkhah, Guido
    Kahlert, Ulf D.
    Maciaczyk, Donata
    Bogiel, Tomasz
    Moellers, Sven
    Schueltke, Elisabeth
    Doebroessy, Mate
    Maciaczyk, Jaroslaw
    RESTORATIVE NEUROLOGY AND NEUROSCIENCE, 2013, 31 (05) : 579 - 595